Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Midazolam for Shivering Prevention in Lower Limb Orthopedic Surgery
NCT07300826Phase 4Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jan 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of dexmedetomidine and midazolam (2 arms), sponsored by Assiut University. Primary endpoint: Incidence of shivering at 1 hour. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
dexmedetomidinemidazolam
Beyond the preview
Go deeper on NCT07300826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07300826.